Liu Xiaofang, Ma Qianqian, Li Zhiming, Xue Yong, Mi Jie, Li Yuxi, Bai Chunfeng, Guo Donglin, Liu Yinping, Liang Yan, Liang Jianqin, Wu Xueqiong
Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Institute of Tuberculosis Research, Senior Department of Tuberculosis, the Eighth Medical Center of People's Liberation Army (PLA) General Hospital, Beijing, China.
People's Liberation Army (PLA) General Hospital, Beijing, China.
Front Immunol. 2025 Jul 30;16:1570992. doi: 10.3389/fimmu.2025.1570992. eCollection 2025.
The pathogenic mechanism underlying (MTB) remains elusive, posing challenges to its diagnosis and treatment. Cuproptosis is a newly identified mechanism of cell death. This study explores the role of cuproptosis-related genes (CRGs) in pulmonary tuberculosis (PTB) to uncover potential diagnostic biomarkers and therapeutic targets.
Differentially expressed gene (DEG) analysis and weighted gene co-expression network analysis (WGCNA) were carried out using the GSE83456 dataset. PTB-associated DEGs were intersected with CRGs to identify PTB-related CRGs. Subsequent analyses included functional enrichment, gene interaction, and protein-protein interaction (PPI) network construction. Hub CRGs were screened out via least absolute shrinkage and selection operator (LASSO) regression and random forest (RF) algorithms. Diagnostic models were subsequently constructed and validated. The associations of immune cell infiltration and pathway with the identified hub genes were evaluated through single-sample gene set enrichment analysis (ssGSEA) and CIBERSORT. Hub gene expressions were validated in the GSE42834 and GSE89403 datasets, as well as by RT-qPCR and Western blot (WB) in PTB and extrapulmonary tuberculosis (EPTB) patients. The GSE89403 dataset and gene expression profiling were leveraged to analyze the differential expression of hub genes and their dynamic changes during treatment.
Seven PTB-related CRGs were significantly upregulated, were significantly upregulated, among which ASPHD2, GK, and GCH1 were identified as hub genes. These genes exhibited high expression levels in patients with PTB and EPTB, with marked reductions observed following treatment. Notable alterations in immune cell infiltration and immune function in PTB patients were closely related to these hub genes, suggesting activation of innate immune responses and suppression of adaptive immune function.
The cuproptosis hub genes ASPHD2, GK, and GCH1 influence the pathogenesis of PTB, and possibly serve as novel diagnostic biomarkers and therapeutic targets.
结核分枝杆菌(MTB)的致病机制仍不清楚,对其诊断和治疗构成挑战。铜死亡是一种新发现的细胞死亡机制。本研究探讨铜死亡相关基因(CRGs)在肺结核(PTB)中的作用,以发现潜在的诊断生物标志物和治疗靶点。
使用GSE83456数据集进行差异表达基因(DEG)分析和加权基因共表达网络分析(WGCNA)。将PTB相关的DEG与CRG进行交叉分析,以鉴定PTB相关的CRG。随后的分析包括功能富集、基因相互作用和蛋白质-蛋白质相互作用(PPI)网络构建。通过最小绝对收缩和选择算子(LASSO)回归和随机森林(RF)算法筛选出核心CRG。随后构建并验证诊断模型。通过单样本基因集富集分析(ssGSEA)和CIBERSORT评估免疫细胞浸润和通路与鉴定出的核心基因的关联。在GSE42834和GSE89403数据集中验证核心基因表达,并通过RT-qPCR和蛋白质免疫印迹(WB)在PTB和肺外结核(EPTB)患者中进行验证。利用GSE89403数据集和基因表达谱分析核心基因的差异表达及其在治疗过程中的动态变化。
7个PTB相关的CRG显著上调,其中ASPHD2、GK和GCH1被鉴定为核心基因。这些基因在PTB和EPTB患者中表达水平较高,治疗后明显降低。PTB患者免疫细胞浸润和免疫功能的显著改变与这些核心基因密切相关,提示固有免疫反应激活和适应性免疫功能抑制。
铜死亡核心基因ASPHD2、GK和GCH1影响PTB的发病机制,可能作为新的诊断生物标志物和治疗靶点。